» Articles » PMID: 2007859

Molecular Characterization of an Autoantigen of PM-Scl in the Polymyositis/scleroderma Overlap Syndrome: a Unique and Complete Human CDNA Encoding an Apparent 75-kD Acidic Protein of the Nucleolar Complex

Overview
Journal J Exp Med
Date 1991 Apr 1
PMID 2007859
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

About 50% of patients with the polymyositis/scleroderma (PM-Scl) overlap syndrome are reported to have autoantibodies to a nuclear/nucleolar particle termed PM-Scl. The particle is composed of several polypeptides of which two have been identified as autoantigens. In this report, human cDNA clone coding for the entire 75-kD autoantigen of the PM-Scl particle (PM-Scl 75) was isolated from a MOLT-4 lambda gt-11 library. The deduced amino acid sequence of the cDNA clone represented a protein of 355 amino acids and 39.2 kD; the in vitro translation product of this cDNA migrated in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) at approximately 70 kD. The aberrant migration of the polypeptide in SDS-PAGE was shown to be related to the COOH half that was rich in acidic residues. Authenticity of the cDNA coding for PM-Scl 75 was shown by immunoreactivity of PM-Scl sera with in vitro translation products and recombinant fusion proteins encoded by the cDNA. In addition, rabbit antibodies raised to recombinant fusion protein reacted in immunofluorescence, immunoblotting, and immunoprecipitation with the characteristic features displayed by human anti-PM-Scl sera.

Citing Articles

Interstitial Lung Disease Is a Major Characteristic of Patients Who Test Positive for Anti-PM/Scl Antibody.

Ge Y, Shu X, He L, Li C, Lu X, Wang G Front Med (Lausanne). 2022; 8:778211.

PMID: 35118087 PMC: 8804089. DOI: 10.3389/fmed.2021.778211.


Clinical utility of ANA-ELISA vs ANA-immunofluorescence in connective tissue diseases.

Alsaed O, Alamlih L, Al-Radideh O, Chandra P, Alemadi S, Al-Allaf A Sci Rep. 2021; 11(1):8229.

PMID: 33859213 PMC: 8050204. DOI: 10.1038/s41598-021-87366-w.


Molecular characteristics and functional differences of anti-PM/Scl autoantibodies and two other distinct and unique supramolecular structures known as "EXOSOMES".

Wermuth P, Jimenez S Autoimmun Rev. 2020; 19(10):102644.

PMID: 32801042 PMC: 7530094. DOI: 10.1016/j.autrev.2020.102644.


Recent Advances in Research Regarding Autoantibodies in Connective Tissue Diseases and Related Disorders.

Murakami K, Mimori T Intern Med. 2018; 58(1):5-14.

PMID: 30146596 PMC: 6367096. DOI: 10.2169/internalmedicine.1423-18.


Anti-PM/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma.

Muro Y, Hosono Y, Sugiura K, Ogawa Y, Mimori T, Akiyama M Arthritis Res Ther. 2015; 17:57.

PMID: 25885224 PMC: 4407870. DOI: 10.1186/s13075-015-0573-x.


References
1.
Reimer G, Scheer U, Peters J, Tan E . Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis/scleroderma overlap syndromes. J Immunol. 1986; 137(12):3802-8. View

2.
Yung B, Busch H, Chan P . Translocation of nucleolar phosphoprotein B23 (37 kDa/pI 5.1) induced by selective inhibitors of ribosome synthesis. Biochim Biophys Acta. 1985; 826(4):167-73. DOI: 10.1016/0167-4781(85)90002-8. View

3.
Kleinschmidt J, Dingwall C, Maier G, Franke W . Molecular characterization of a karyophilic, histone-binding protein: cDNA cloning, amino acid sequence and expression of nuclear protein N1/N2 of Xenopus laevis. EMBO J. 1986; 5(13):3547-52. PMC: 1167392. DOI: 10.1002/j.1460-2075.1986.tb04681.x. View

4.
Earnshaw W, Sullivan K, Machlin P, Cooke C, Kaiser D, Pollard T . Molecular cloning of cDNA for CENP-B, the major human centromere autoantigen. J Cell Biol. 1987; 104(4):817-29. PMC: 2114438. DOI: 10.1083/jcb.104.4.817. View

5.
Bravo R, Frank R, Blundell P . Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature. 1987; 326(6112):515-7. DOI: 10.1038/326515a0. View